Two models for multiple sclerosis: Experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 6, 1996, Pages 673-686

  Tsunoda, Ikuo ^a   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Experimental allergic encephalomyelitis; Multiple sclerosis; Murine encephalomyelitis virus; Review

Indexed keywords

ALLERGIC ENCEPHALITIS; ANIMAL MODEL; AUTOIMMUNITY; DEMYELINATION; LYMPHOCYTIC INFILTRATION; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0029888979     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199606000-00001     Document Type: Review

References (136)

1. Martin R, McFarland HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995;32:121-82
2. Challoner PB, Smith KT, Parker JD, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995;92:7440-44
3. Liedtke W, Malessa R, Faustmann PM, Eis-Hübinger A. Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J Neurovirol 1995;1:253-58
4. Bansil S, Cook SD, Rohowsky-Kochan C. Multiple sclerosis: Immune mechanism and update on current therapies. Ann Neurol 1995;37:S87-S101
5. Barbano RL, Dal Canto MC. Serum and cells from Theiler's virus-infected mice fail to injure myelinating cultures or to produce in vivo transfer of disease. The pathogenesis of Theiler's virus-induced demyelination appears to differ from that of EAE. J Neurol Sci 1984:66:283-93
6. Lang W, Wiley C, Lampert P. Theiler's virus encephalomyelitis is unaffected by treatment with myelin components. J Neuroimmunol 1985;9:109-13
7. Rose JW. Virus-induced demyelination: From animal models to human diseases. Mayo Clin Proc 1992;67:903-6
8. Fujinami RS. Viruses and autoimmunity. In: van Regenmortel MHV, Neurath AR, eds. Immunochemistry of viruses, II. The basis for serodiagnosis and vaccines. Amsterdam: Elsevier Science Publishers B.V. (Biomedical Division) 1990:75-82
9. Theiler M. Spontaneous encephalomyelitis of mice - A new virus disease. Science 1934;80:122
10. Daniels JB, Pappenheimer AM, Richardson S. Observations on encephalomyelitis of mice (DA strain). J Exp Med 1952;96:517-30
11. Lipton HL. Theiler's virus infection in mice: An unusual biphasic disease process leading to demyelination. Infect Immun 1975;11: 1147-55
12. Rivers TM, Sprunt DH, Berry GP. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 1933;58:39-53
13. Morgan IM. Allergic encephalomyelitis in monkeys in response to injection of normal monkey cord. J Bacteriol 1946;51:614-15
14. Kabat EA, Wolf A, Bezer AE. Rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of brain tissue with adjuvants. Science 1946;104:362-63
15. Paterson PY. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 1960;111:119-36
16. Yamada M, Zurbriggen A, Fujinami RS. Pathogenesis of Theiler's murine encephalomyelitis virus. Adv Virus Res 1991;39:291-320
17. Kappel CA, Melvold RW, Kim BS. Influence of sex on susceptibility in the Theiler's murine encephalomyelitis virus model for multiple sclerosis. J Neuroimmunol 1990;29:15-19
18. Steiner CM, Rozhon EJ, Lipton HL. Relationship between host age and persistence of Theiler's virus in the central nervous system of mice. Infect Immun 1984;43:432-34
19. Rodriguez M, Leibowitz JL, Powell HC, Lampert PW. Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus. Lab Invest 1983;49:672-79
20. Jansen I, Fujinami RS. Theiler's murine encephalomyelitis virus permissiveness in a variety of cell lines. (Abstract) Abstract book of Keystone Symposia on Molecular and Cellular Biology, Cell Biology of Virus Entry, Replication and Pathogenesis 1996:18
21. Seil FJ. Effects of humoral factors on myelin in organotypic cultures. In: Herndon RM, Seil FJ, eds. Multiple sclerosis: Current status of research and treatment. New York: Demos Publications, 1994:33-50
22. Fujinami RS, Paterson PY. Induction of experimental allergic encephalomyelitis in suckling Lewis rats: Role of age and type of sensitizing neuroantigen. J Immunol 1977;119:1634-38
23. Dal Canto MC, Fujinami RS, Paterson PY. Experimental allergic encephalomyelitis in suckling Lewis rats. Comparison with the disease in adult animals. Lab Invest 1977;37:395-405
24. Cua DJ, Hinton DR, Stohlman SA. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J Immunol 1995;155:4052-59
25. Swanborg RH, Gould KE, Stepaniak JA. Letter to the editor. J Immunol 1994;153:2352
26. Fritz RB, McFarlin DE. Encephalitogenic epitopes of myelin basic protein. Chem Immunol 1989;46:101-25
27. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993;72:551-60
28. Sobel RA, Greer JM, Kuchroo VK. Minireview: Autoimmune responses to myelin proteolipid protein. Neurochem Res 1994;19: 915-21
29. Tuohy VK. Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: A review. Neurochem Res 1994;19:935-44
30. Amor S, Groome N, Linington C, et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 1994;153:4349-56
31. Kerlero de Rosbo N, Mendel I, Ben-Nun A. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: Preliminary analysis of MOG T cell epitopes. Eur J Immunol 1995;25: 985-93
32. Cohen O, Sela B, Schwartz M, Eshhar N, Cohen IR. Multiple sclerosis-like disease induced in rabbits by immunization with brain gangliosides. Isr J Med Sci 1981;17:711-14
33. Tsukada N, Koh C, Yanagisawa N, Okano A, Behan WMH, Behan PO. A new model for multiple sclerosis: Chronic experimental allergic encephalomyelitis induced by immunization with cerebral endothelial cell membrane. Acta Neuropathol (Berl) 1987;73:259-66
34. Kojima K, Berger T, Lassmann H et al. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia. J Exp Med 1994;180:817-29
35. Tsunoda I, Iwasaki Y, Terunuma H, Sako K, Ohara Y. A comparative study of acute and chronic diseases induced by two sub-groups of Theiler's murine encephalomyelitis virus. Acta Neuropathol (Berl) 1996 (in press)
36. Yamada M, Zurbriggen A, Fujinami RS. The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection. Am J Pathol 1990;137:1467-79
37. Shin T, Kojima T, Tanuma N, Ishihara Y, Matsumoto Y. The sub-arachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis. J Neuroimmunol 1995;56:171-77
38. Tabira T. Autoimmune demyelination in the central nervous system. Ann NY Acad Sci 1988;540:187-201
39. Iwasaki Y, Akizuki S, Miwa M. Role of monocyte/macrophage lineage cells in HAM/TSP. Ann NY Acad Sci 1994;724:414-16
40. Lipton HL, Dal Canto MC. Theiler's virus-induced demyelination: Prevention by immunosuppression. Science 1976;192:62-64
41. Roos RP, Wollmann R. DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann Neurol 1984;15:494-99
42. Rosenthal A, Fujinami RS, Lampert PW. Mechanism of Theiler's virus-induced demyelination in nude mice. Lab Invest 1986;54: 515-22
43. Fujinami RS, Rosenthal A, Lampert PW, Zurbriggen A, Yamada M. Survival of athymic (nulnu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody. J Virol 1989;63:2081-87
44. Lampert PW, Fujinami RS, Rodriguez M, Leibowitz JL, Lang W. Further studies on the pathogenesis of Theiler's murine encephalomyelitis. (Abstract) J Neuropathol Exp Neurol 1983;42:326
45. Lipton HL, Twaddle G, Jelachich ML. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol 1995;69:2525-33
46. Sakai K, Namikawa T, Kunishita T, Yamanouchi K, Tabira T. Studies of experimental allergic encephalomyelitis by using encephalitogenic T cell lines and clones in euthymic and athymic mice. J Immunol 1986;137:1527-31
47. Hinrichs DJ, Humphres RC. The response of the nude (athymic) rat to actively induced and adoptively transferred experimental allergic encephalomyelitis. J Immunol 1983;131:4-5
48. Sedgwick J, Brostoff S, Mason D. Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. J Exp Med 1987;165:1058-75
49. Gausas J, Paterson PY, Day ED, Dal Canto MC. Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats. Cell Immunol 1982;72:360-66
50. Levine S, Sowinski R. Allergic encephalomyelitis: New form featuring polymorphonuclear leukocytes. Science 1971;171:498-99
51. Willenborg DO, Sjollema P, Danta G. Immunoregulation of passively induced allergic encephalomyelitis. J Immunol 1986;136: 1676-79
52. Paterson PY, Hanson M. Cyclophosphamide inhibition of experimental allergic encephalomyelitis and cellular transfer of the disease in Lewis rats. J Immunol 1969;103:1311-16
53. Levine S, Prineas J, Scheinberg LC. Allergic encephalomyelitis: Inhibition of cellular passive transfer by X-radiation. Proc Soc Exp Biol Med 1969;131:986-90
54. Matsumoto Y, Kawai K, Fujiwara M. Hemorrhagic autoimmune encephalomyelitis induced by adoptive transfer of activated semiallogenic spleen cells into irradiated rats. Am J Pathol 1988;133: 306-15
55. Smith SB, Waksman BH. Passive transfer and labelling studies on the cell infiltrate in experimental allergic encephalomyelitis. J Pathol 1969;99:237-44
56. Cross AH, O'Mara T, Raine CS. Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: Implications for the study of multiple sclerosis. Neurology 1993;43:1028-33
57. + T cells that induce experimental allergic encephalomyelitis. J Neuroimmunol 1992;40:57-70
58. + population during recovery. J Neuroimmunol 1993;48:105-18
59. Wisniewski HM, Bloom BR. Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction. J Exp Med 1975;141:346-59
60. Wada Y, Fujinami RS. Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virus. Am J Pathol 1993;143:221-29
61. Aubert C, Brahic M. Early infection of the central nervous system by the GDVII and DA strains of Theiler's virus. J Virol 1995;69: 3197-3200
62. Rauch HC, Montgomery IN. The role of the immune response in TMEV infection and the development of late onset demyelination. J Immunol 1986;136:2136-40
63. Levy M, Aubert C, Brahic M. Theiler's virus replication in brain macrophages cultured in vitro. J Virol 1992;66:3188-93
64. Clatch RJ, Miller SD, Metzner R, Dal Canto MC, Lipton HL. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 1990;176:244-54
65. Williams AE, Blakemore WF. Monocyte-mediated entry of pathogens into the central nervous system. Neuropathol Appl Neurobiol 1990;16:377-92
66. Zurbriggen A, Fujinami RS. Theiler's virus infection in nude mice: Viral RNA in vascular endothelial cells. J Virol 1988;62:3589-96
67. Iwasaki Y. Spread of virus within the central nervous system. In: Baer GM, ed. The natural history of rabies, 2nd edition. Boca Raton, FL: CRC Press, 1991
68. Iwasaki Y, Yamamoto T, Konno H, Iizuka H, Kudo H. Eradication of herpes simplex virus persistence in rat trigeminal ganglia by retrograde axoplasmic transport. J Virol 1986;59:242-48
69. Matsumoto Y, Hanawa H, Tsuchida M, Abo T. In situ inactivation of infiltrating T cells in the central nervous system with autoimmune encephalomyelitis. The role of astrocytes. Immunology 1993;79:381-90
70. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994;78:399-408
71. + T cells in the central nervous system in experimental allergic encephalomyelitis. J Neuroimmunol 1992;38:255-62
72. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988;239:290-92
73. Ohmori K, Hong Y, Fujiwara M, Matsumoto Y. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis. Evidence suggesting that most infiltrating T cells do not proliferate in the target organ. Lab Invest 1992;66:54-62
74. Masuyama J, Minato N, Kano S. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. J Clin Invest 1986;77:1596-1605
75. Heber-Katz E, Acha-Orbea H. The V-region disease hypothesis: Evidence from autoimmune encephalomyelitis. Immunol Today 1989;10:164-69
76. Yamamura T, Kondo T, Sakanaka S, et al. Analysis of T cell antigen receptors of myelin basic protein specific T cells in SJL/J mice demonstrates an α chain CDR3 motif associated with encephalitogenic T cells. Int Immunol 1994;6:947-54
77. Rodriguez M, Prayoonwiwat N, Zhou P, David C. Expression of T cell receptor Vβ transcripts in central nervous system of mice susceptible and resistant to Theiler's virus-induced demyelination. J Neuroimmunol 1993;47:95-100
78. Lassmann H, Zimprich F, Rössler K, Vass K. Inflammation in the nervous system. Basic mechanisms and immunological concepts. Rev Neurol (Paris) 1991;147:763-81
79. Linsley PS. The CD28/CTLA-4:B7 receptor system in experimental autoimmune encephalomyelitis. J Clin Invest 1995;95:2429-30
80. Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: Intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev 1995;20:269-87
81. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway Jr CA. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 1993;177:57-68
82. Sako K, Iwasaki Y, Ohara Y, Tsunoda I, Okumura K. Anti-very late antigen-4 antibody suppresses acute active experimental allergic encephalomyelitis in Lewis rats. (Abstract) J Neuropathol Exp Neurol 1993;52:310
83. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 1992;356:63-66
84. Archelos JJ, Jung S, Mäurer M, et al. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann Neurol 1993;34:145-54
85. Welsh CT, Rose JW, Hill KE, Townsend JJ. Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1α. J Neuroimmunol 1993;43:161-68
86. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991;28:254-60
87. Konno H, Yamamoto T, Suzuki H, et al. Targeting of adoptively transferred experimental allergic encephalitis lesion at the sites of Wallerian degeneration. Acta Neuropathol (Berl) 1990;80:521-26
88. Welsh CJR, Tonks P, Nash AA, Blakemore WF. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J Gen Virol 1987;68:1659-67
89. Rodriguez M, Pierce ML, Howie EA. Immune response gene products (Ia antigens) on glial and endothelial cells in virus-induced demyelination. J Immunol 1987;138:3438-42
90. Friedmann A, Frankel G, Lorch Y, Steinman L. Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: Critical importance of timing of treatment. J Virol 1987;61:898-903
91. Rodriguez M, Lafuse WP, Leibowitz J, David CS. Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology 1986;36:964-70
92. Clatch RJ, Lipton HL, Miller SD. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: Correlation with clinical signs. J Immunol 1986;136:920-27
93. Miller SD, Clatch RJ, Pevear DC, Trotter JL, Lipton HL. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. J Immunol 1987;138:3776-84
94. + T cell line specific for an immunodominant VP2 epitope. J Immunol 1994;152:919-29
95. Lindsley MD, Rodriguez M. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J Immunol 1989;142: 2677-82
96. Njenga MK, Pavelko KD, Baisch J, Lin X, David C, Leibowitz J, Rodriguez M. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J Virol 1996;70:1729-37
97. Nicholson SM, Peterson JD, Miller SD, Wang K, Dal Canto MC, Melvold RW. BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Neuroimmunol 1994;52:19-24
98. Olsson T. Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology 1995;45: S11-S15
99. Sun D, Wekerle H. Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature 1986;320:70-72
100. Fallis RJ, McFarlin DE. Chronic relapsing experimental allergic encephalomyelitis. Cytotoxicity effected by a class II restricted T cell line specific for an encephalitogenic epitope. J Immunol 1989;143:2160-2165
101. Risau W, Engelhardt B, Wekerle H. Immune function of the bloodbrain barrier: Incomplete presentation of protein (auto-) antigens by rat brain microvascular endothelium in vitro. J Cell Biol 1990;110:1757-1766
102. Lin X, Thiemann R, Pease LR, Rodriguez M. VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of BIO mice. Virology 1995;214:91-99
103. Lindsey MD, Patick AK, Prayoonwiwat N, Rodriguez M. Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Thieler's virus: A model for multiple sclerosis. Mayo Clin Proc 1992;67:829-38
104. Altintas A, Cai Z, Pease LR, Rodriguez M. Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus. J Immunol 1993;151:2803-12
105. Neumann H, Cavalié A, Jenne DE, Wekerle H. Induction of MHC class I genes in neurons. Science 1995;269:549-52
106. Rodriguez M, Sriram S. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J Immunol 1988;140:2950-55
107. + T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J Gen Virol 1992;73: 1861-65
108. Pullen LC, Miller SD, Dal Canto MC, Kim BS. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur J Immunol 1993;23:2287-93
109. 2-microglobulin-deficient mice. J Virol 1993;67:589-92
110. + suppressor cells differentially affect the productions of IFN-γ by effector cells of experimental autoimmune encephalomyelitis. J Immunol 1989;143:3492-97
111. Weiner HL, Friedman A, Miller A, et al. Oral tolerance: Immunologic mechanisms and treatment of animal and human organspecific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994;12:809-37
112. Sun D, Qin Y, Chluba J, Epplen JT, Wekerle H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 1988;332:843-45
113. Ofosu-Appiah W, Mokhtarian F. Characterization of a T suppressor cell line that downgrades experimental allergic encephalomyelitis in mice. Cell Immunol 1991;135:143-53
114. + T cells in murine experimental allergic encephalomyelitis. Science 1992;256:1213-15
115. + (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis. Eur J Immunol 1988;18:495-502
116. + mice. Science 1992;256:1210-13
117. + cells in T cell receptor peptide-induced clonal unresponsiveness. Science 1993;259:91-94 (published erratum appears in Science 1993;260:280)
118. Rauch HC, Montgomery IN, Hinman CL, Harb W, Benjamins JA. Chronic Theiler's virus infection in mice: Appearance of myelin basic protein in the cerebrospinal fluid and serum antibody directed against MBP. J Neuroimmunol 1987;14:35-48
119. Fujinami RS. Immune responses against myelin basic protein and/or galactocerebroside cross-react with viruses: Implications for demyelinating disease. Curr Top Microbiol Immunol 1989;145:93-100
120. Fujinami RS, Zurbriggen A, Powell HC Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures. J Neuroimmunol 1988;20:25-32
121. Yamada M, Zurbriggen A, Fujinami RS. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J Exp Med 1990;171:1893-1907
122. Rodriguez M, Quddus J. Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination. J Neuroimmunol 1986;13:159-74
123. Jelachich ML, Bandyopadhyay P, Blum K, Lipton HL. Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation. Virology 1995;209:437-44
124. Liuzzi GM, Riccio P, Dal Canto MC. Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: Comparison between susceptible and resistant mice. J Neuroimmunol 1995;62:91-102
125. Brosnan CF, Bornstein MB, Bloom BR. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol 1981;126:614-20
126. Huitinga I, van Rooijen N, de Groot CJA, Uitdehaag BMJ, Dijkstra CD. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990;172:1025-33
127. Cash E, Minty A, Ferrara P, Caput D, Fradelizi D, Rott O. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol 1994;153: 4258-67
128. Tsukamoto T, Ishikawa M, Yamamoto T. Suppressive effects of TNF-α on myelin formation in vitro. Acta Neurol Scand 1995;91: 71-75
129. Dietzshold B, Schwaeble W, Schäfer MKH, et al. Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis. J Neurol Sci 1995;130:11-16
130. Okuda Y, Nakatsuji Y, Fujimura H, et al. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J Neuroimmunol 1995;62:103-12
131. Brosnan CF, Cammer W, Norton WT, Bloom BR. Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis. Nature 1980;285:235-37
132. Tsunoda I, Kurtz CIB, Fujinami RS. Apoptosis as a possible mechanism for elimination of virus infected cells from the central nervous system leading to demyelinating disease. (Abstract) Abstract book of Keystone Symposia on Molecular and Cellular Biology, Cell Biology of Virus Entry, Replication and Pathogenesis 1996:45
133. Pender MP, Nguyen KB, McCombe PA, Kerr JFR. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 1991;104:81-87
134. Schmied M, Breitschopf H, Gold R, et al. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 1993;143:446-52
135. MacPhee IAM, Antoni FA, Mason DW. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 1989;169:431-45
136. Critchfield JM, Racke MK, Zúñiga-Pflücker JC et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994;263:1139-43